Discover our top-rated, regulated brokers. Compare platforms, fees and features, and explore the latest broker offers.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs and FX are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
AskTraders may earn a commission when you click through to a broker.
Berkeley Group shares closed today at their highest level since June, above their 60-session range, though the housebuilder’s stock is still down for the year.
Ceres Power tops the FCA’s most shorted UK stocks at 18.71% of issued capital, barely changed on the previous report. Vistry recorded the biggest fall, WH Smith the…
Prudential shares rose for a seventh consecutive session yesterday, closing at 944.2p, two sessions short of the longest winning run in the stock’s price history, though still well…
BAE Systems shares fell more than 5% in early London trading today, the second-sharpest one-day drop for the defence group in about six months, to 1,966p by 9…
MedPal AI’s New Health weight-loss clinic grew October revenue by a third to £3.63m as revenue from returning customers more than doubled, though funding talks are still at…
Gold has jumped, and miners lead the FTSE 100 higher on Wednesday morning, while the FTSE 250 is flat.
Gem Diamonds sold fewer carats in the third quarter but took in more revenue, helped by large stones including a 347 carat diamond. It raised full-year production and…
Foresight Solar Fund’s net asset value slipped 1.1p a share in the third quarter as higher discount rates and the dividend outweighed time value, power prices and inflation,…
Weir says group orders rose 8% in the third quarter and that it is on track for market expectations, but shares are down early on Wednesday, with fourth-quarter…
Barratt Redrow left full-year guidance unchanged in its AGM trading update this morning, but its underlying private reservation rate fell and completions dropped 12.1%, with rental deals lifting…
Coca-Cola HBC has raised its 2026 organic revenue growth guidance after third-quarter sales grew 9.0%, but left its profit growth target unchanged. The shares have yet to trade…
Zotefoams says non-footwear markets are growing strongly, but footwear sales fell faster than planned in the third quarter. The board still expects full-year adjusted profit in line with…
Smith+Nephew has lowered its full-year profit outlook on weak US hip and knee sales and confirmed that talks with Johnson & Johnson about its Orthopaedics business have ended,…
Trainline held its full-year guidance as its European consumer arm turned profitable for the first time, lifting first-half adjusted EBITDA 7% even as revenue slipped 1% and UK…
Marks and Spencer’s first-half adjusted profit has rebounded from last year’s cyber-attack hit, led by Food, while Fashion, Home & Beauty profitability lagged and full-year guidance is only…
Qinetiq shares rose for a tenth straight session today, closing at 549.5p, the longest run of daily gains in the records held, which begin in September 2021.
Jefferies upgraded Centrica to buy and raised its target price to 200p, saying the market is overlooking the business’s visibility and growth. Tuesday’s morning spike faded by the…
IWG, the flexible workspace provider, posted its largest one-day gain in six months today, closing at 214.2p after third-quarter results and a statement that full-year adjusted EBITDA should…
International Biotechnology Trust returned 73.6% to shareholders in the year to the 31st of August 2026, in a year when takeovers of its portfolio companies were central, though…
Shield Therapeutics has withdrawn its goal of an operating profit for 2026 and now expects a single-digit million-dollar loss, as full US control of its iron treatment ACCRUFeR…
Likewise Group, the AIM-listed flooring distributor, says October revenue rose 36.7% and now expects full-year pre-tax profit of at least £6m, materially ahead of market expectations, as it…
Sign up to our free Morning Markets email, every weekday before the open.
